- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/84 - Nitrogen atoms
Patent holdings for IPC class C07D 239/84
Total number of patents in this class: 291
10-year publication summary
|
28
|
20
|
17
|
25
|
27
|
24
|
25
|
20
|
8
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Aic246 AG & Co. KG | 28 |
17 |
| Neupharma, Inc. | 73 |
14 |
| Cornell University | 3444 |
10 |
| ArQule, Inc. | 132 |
9 |
| Blueprint Medicines Corporation | 259 |
8 |
| Gilead Sciences, Inc. | 2242 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
7 |
| Merck Patent GmbH | 5739 |
6 |
| Araxes Pharma LLC | 90 |
6 |
| Institute of Organic Chemistry and Biochemistry of the AS CR, v.v.i. | 13 |
6 |
| Abbisko Therapeutics Co., Ltd. | 120 |
6 |
| Deciphera Pharmaceuticals, LLC | 267 |
5 |
| Eisai R&D Management Co., Ltd. | 1164 |
5 |
| Merck Sharp & Dohme LLC | 3738 |
5 |
| Bristol-myers Squibb Company | 4764 |
4 |
| Merck Sharp & Dohme Corp. | 2184 |
4 |
| Pfizer Inc. | 3413 |
4 |
| Convergene LLC | 12 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
4 |
| Other owners | 151 |